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Objectives: Cardiac rehabilitation is underused and
its quality in practice is unclear. A quality indicator is
a measurable element of clinical practice
performance. This study aimed to propose a set of
quality indicators for cardiac rehabilitation following
an acute coronary event in the Japanese population
and conduct a small-size practice test to confirm
feasibility and applicability of the indicators in real-
world clinical practice.
Design and setting: This study used a modified
Delphi technique (the RAND/UCLA appropriateness
method), a consensus method which involves an
evidence review, a face-to-face multidisciplinary panel
meeting and repeated anonymous rating. Evidence to
be reviewed included clinical practice guidelines
available in English or Japanese and existing quality
indicators. Performance of each indicator was
assessed retrospectively using medical records at a
university hospital in Japan.
Participants: 10 professionals in cardiac
rehabilitation for the consensus panel.
Results: In the literature review, 23 clinical practice
guidelines and 16 existing indicators were identified
to generate potential indicators. Through the
consensus-building process, a total of 30 indicators
were assessed and finally 13 indicators were
accepted. The practice test (n=39) revealed that 74%
of patients underwent cardiac rehabilitation. Median
performance of process measures was 93% (IQR 46–
100%). ‘Communication with the doctor who referred
the patient to cardiac rehabilitation’ and ‘continuous
participation in cardiac rehabilitation’ had low
performance (32% and 38%, respectively).
Conclusions: A modified Delphi technique identified
a comprehensive set of quality indicators for cardiac
rehabilitation. The single-site, small-size practice test
confirmed that most of the proposed indicators were
measurable in real-world clinical practice. However,
some clinical processes which are not covered by
national health insurance in Japan had low
performance. Further studies will be needed to clarify
and improve the quality of care in cardiac
rehabilitation.
INTRODUCTION
Acute coronary syndrome is a leading cause of
death and a major social burden in the
world.1 Developments in coronary interven-
tions, surgical procedures, pharmacological
treatments and lifestyle modiﬁcations (eg,
smoking cessation) have improved prognosis,
prevented recurrence and reduced mortality
in patients who experience acute coronary
events.2 3 In urban and/or suburban areas of
Japan, however, the incidence of myocardial
infarction and sudden cardiac death among
men has increased in the past few decades,
although the trend in rural areas is unclear.4–6
Previous studies have demonstrated the
effectiveness of comprehensive cardiac
rehabilitation (CR) on the survival and
quality of life of patients with coronary heart
disease.7 Yet CR referral rates vary according
to characteristics of patients, specialty units
and hospitals.8–14 Moreover, little is known
about the quality of programmes in real-
world clinical settings.
Quality indicators are measurable elements
of practice performance for which there is
evidence or consensus. Process indicators, in
Strengths and limitations of this study
▪ This is the first study to assess the utility of a
whole set of quality indicators for cardiac
rehabilitation that were established with the
RAND/UCLA appropriateness method.
▪ A guideline-based modified Delphi technique was
used and medical records were reviewed as a
practice test before implementing indicators in
real-world clinical practice.
▪ The composition of our panel members may
lead to a biased selection of indicators.
▪ The single-site, small-size practice test may limit
to generalise the performance of indicators.
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particular, are used to express the proportion of patients
who receive appropriate care. They can highlight and
reveal quality issues, which in turn enable the formula-
tion of solutions for improvement.15–17 The use of
quality indicators has increased in Japan, particularly in
cancer care settings.18
Quality indicators for cardiovascular disease preven-
tion and CR have been developed in European coun-
tries, the USA and Canada, but not in Asia including
Japan.19–23 Additionally, a practice test prior to real
usage is needed when developing quality indicators.24 25
However, previous practice tests examined only a part of
the indicator set in the CR ﬁeld.26 27
This study aims to (1) propose quality indicators for CR
following an acute coronary event (eg, acute myocardial
infarction and unstable angina), as these diseases are the
most common indications for CR, (2) conduct a small-
size, pilot practice test with the whole set of the proposed
indicators to conﬁrm the feasibility and applicability
before using them in real-world clinical practice and (3)
describe a detailed process of developing quality indica-
tors for applicability to other clinical circumstances.
METHODS
Indicator development
Overview of the development process
This study was conducted by the task force on evidence-
based healthcare and clinical practice guidelines under
the Ministry of Health, Welfare and Labour in Japan.
The aim was to propose the common method to
develop quality indicators.
A modiﬁed Delphi technique (the RAND Corporation
(RAND)/University of California, Los Angeles (UCLA)
appropriateness method), which has been widely used
to develop healthcare quality indicators, was used.28 The
method integrates an evidence review, a face-to-face
multidisciplinary panel meeting and repeated anonym-
ous rating for consensus building.
Systematic search of evidence
Kötter et al24 previously reported that methods for quality
indicator development based on clinical guidelines are
increasing and may help in the efﬁcient gathering of evi-
dence when considering indicators. On this basis, we
searched existing clinical practice guidelines available in
English or Japanese and quality indicators related to CR
after an acute coronary event developed in countries
other than Japan. Speciﬁcally, we searched electronic
databases with the search terms ‘cardiovascular disease’,
‘cardiovascular system’, ‘cardiology’, ‘cardiac’, ‘cardiovas-
cular’ and ‘rehabilitation’ in August 2011. The following
databases were used: one quality indicator database
(Agency for Healthcare Research and Quality (AHRQ)
National Quality Measures Clearinghouse); nine
guideline databases (AHRQ National Guideline
Clearinghouse, National Institute for Health and Care
Excellence (NICE) Find Guidance, National Health
Service (NHS) Evidence, Minds, PEDro, Guidelines
International Network, Australian Government National
Health Medical Research Council, Canadian Medical
Association and British Intercollegiate Guidelines
Network) and three medical literature databases
(MEDLINE, CINAHL and ICHUSHI). The Japanese
Association of Cardiac Rehabilitation website and the
Japanese Circulation Society website were also reviewed
for Japanese guidelines on CR. The search was limited to
the English or Japanese language. In 2011, we searched
literature published from April 2006 to March 2011,
because clinical guidelines are generally outdated after
5 years.29 30 Two appraisers (SO and NK) evaluated the
quality of the selected guidelines with the AGREE II
instrument, which is the established tool for this
purpose.31 For each guideline, overall assessments using
AGREE II by two appraisers were averaged.
In order to generate indicators to be evaluated in a
subsequent consensus panel, clinical practices which
were strongly recommended in the selected guidelines
were extracted. They were merged with existing quality
indicators and applied to a structured format of the
modiﬁed American College of Cardiology (ACC)/
American Heart Association (AHA) methodology.32 One
researcher (SO) assembled the indicators and was super-
vised by two experts: TN, an epidemiologist experienced
in the development of a variety of Japanese clinical prac-
tice guidelines and also the chair of the task force on
evidence-based healthcare and clinical practice guide-
lines, and KU, a cardiologist familiar with CR and
evidence-based medicine.
Multidisciplinary panel
Panel members responsible for consensus development
were selected from registered instructors of CR licensed
by the Japanese Association of Cardiac Rehabilitation.
Licensure status requires individuals to have practised
CR for at least 1 year, submitted 10 case reports and
passed an authorised examination. To assemble the
multidisciplinary group, we attempted to select more
than one person from each profession related to CR
(cardiologists, nurses, physical therapists, clinical labora-
tory technicians, registered dietitians, health ﬁtness pro-
grammers and clinical psychologists). The sampling
strategy was non-random selection aiming to seek partici-
pants who would be informative, with recommendations
by KU and approval by SO and TN. KU was a member
of the committee on Japanese guidelines for CR and
appointed as president of the Japan Association of
Cardiac Rehabilitation in 2014. Each panel member
signed a consent form for the present study. The indica-
tor development part of this study was approved by the
Kyoto University Graduate School and Faculty of
Medicine, Ethics Committee.
Consensus building
On the basis of the modiﬁed Delphi technique, panel
members formed a consensus regarding indicators in
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three rounds. In round 1, members individually evalu-
ated indicators using a nine-point scale postal question-
naire. In round 2, they reconvened for a 1-day
face-to-face meeting to discuss, revise and individually
evaluate potential indicators, and then suggest add-
itional ones at a later meeting. In round 3, they dis-
cussed additional indicators by email instead of a
face-to-face meeting and evaluated them with the same
postal questionnaire as above.
Round 1
A set of documents that described the quality indicators
was distributed to 10 panel members. Members were
then given 2 weeks to individually rate each indicator
with a nine-point scale questionnaire, adapted from the
nine domains suggested by Spertus et al:32 evidence-
based, interpretable, actionable, denominator, numer-
ator, validity, reliability, feasibility and overall assessment.
We planned more than one reminder with email or tele-
phone for non-responders.
Round 2
A 1-day face-to-face panel meeting was held. Panel
members anonymously shared their results from round
1 and discussed each indicator. When the panel
members felt the necessity, they revised the elements of
each potential indicator considering a member’s sugges-
tion. Any disagreements were resolved through discus-
sion. Finally, the panel rated the revised indicators
individually, using the same questionnaire from round 1.
At the end of the meeting, we asked members to
suggest additional indicators that might be important
for measuring the quality of CR services in Japan that
had not been examined by the panel prior to the
meeting.
Round 3
Additional indicators were developed from suggestions
during the panel meeting (round 2). A document
describing the new indicators was sent to panel
members electronically, asking for any modiﬁcations.
The indicators were then revised according to the sug-
gestions and sent to panel members by mail to rate
using the same questionnaire from round 1.
Selection criteria
Quality indicators were adopted according to the follow-
ing criteria: the median individual rating during round
2 or 3 was >7, and the number of panel members who
gave a rating <3 was two or fewer.
Pilot practice test for feasibility and adaptability
Study patients
Selected patients were those who (1) experienced an
acute myocardial infarction or unstable angina and (2)
were admitted to Kyoto University Hospital, which pro-
vides acute-to-recovery care in Japan, between 1 January
2013 and 30 June 2013. On the basis of the Ethical
Guidelines for Epidemiological Research established by
the Ministry of Education, Culture, Sports, Science and
Technology and Ministry of Health, Labour and Welfare
in Japan, we prepared a protocol mentioning that the
investigators disclose requisite information on the study
and, consequently, the protocol for the practice test was
approved by the university ethics committee.
Data collection
Data were collected from Kyoto University’s electronic
medical records in January 2014. Records regarding
eating habits (QI-2), coronary risk factors (QI-3), psy-
chological responses (QI-4), tobacco and alcohol (QI-5),
exercise capacity (QI-6), deﬁnition of the programme
end period (QI-8), and work and leisure (QI-10) were
available in the implementation planning sheets for CR
per national insurance regulations. Professionals
assessed a suitable period with regard to QI-8 for every
patient in view of their clinical situation and recorded it
in the planning sheet as routine in the hospital. Records
on education regarding the importance of adherence
to prescription medication (QI-12) were available in
pharmacist instruction reports, also per national insurance
regulations. SO and NK assessed performance of the indi-
cators based on each patient’s records. Disagreements
were resolved by discussion.
Data analysis
Patients with acute myocardial infarction and unstable
angina were selected consecutively during the study
period from Kyoto University Hospital via coronary cath-
eterisation records for measurement with the indicators.
Percentage scores were obtained for each indicator as
follows: the number of times the indicator was met/the
number of participants (excluding those with obvious
reasons for not implementing the process as deﬁned by
the indicator)×100. Medians of indicator scores were
also computed as an overall quality score of the
programme.
Disclosure and update
The adopted indicators were disclosed and externally
reviewed at a symposium during the annual meeting of
the Japanese Association of Cardiac Rehabilitation, of
which KU was the president in July 2014. Considering
suggestions from external experts, an indicator regard-
ing referral to CR was updated in October 2015 based




The literature review identiﬁed 38 quality indicators
from the AHRQ National Quality Measures
Clearinghouse, of which 16 were selected according to
the criteria (ﬁgure 1). Searches of guideline databases
and medical literature databases identiﬁed 894 articles
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(103 from the AHRQ National Guideline Clearinghouse,
121 from NICE Find Guidance, 487 from NHS Evidence,
2 from Minds, 11 from PEDro, 25 from the Guidelines
International Network, 6 from the Australian
Government National Health Medical Research Council,
9 from the Canadian Medical Association, 22 from the
British Intercollegiate Guidelines Network, 74 from
MEDLINE, 24 from CINAHL and 10 from ICHUSHI).
Seven additional guidelines were identiﬁed from the
Japanese academic society websites. In total, 23 guide-
lines met our eligibility criteria. The average of overall
quality scores based on AGREE II was 5.0 out of a pos-
sible 7 (minimum to maximum 3.5–6.0). A total of 27
potential indicators created from the aforementioned 16
existing indicators and 23 guidelines were included for
panel assessment.33–55
Ten Japanese clinicians in CR were invited to the
panel, including two cardiologists, two nurses, two phys-
ical therapists, one clinical laboratory technician, one
registered dietitian, one health ﬁtness programmer and
one clinical psychologist (a member of the committee
on Japanese guidelines for CR). Finally, all of them par-
ticipated in the consensus development process.
The round 2 ratings accepted six indicators (ﬁgures 2
and 3). Although an indicator regarding referral to CR
from outpatient settings had been discarded in this
round, it was later accepted in the update period as a
modiﬁed indicator (QI-1, table 1), the rating of which
was a median of 8, and minimum to maximum of 4–9
(ﬁgure 3).
The panel had a debate about the arrangement of
indicators regarding coronary risk factors. The members
understood the importance of assessment and education
for each risk factor. However, at the same time, they con-
cerned measurement burden in clinical practice due to
a lot of indicators. They considered that practitioners,
generally in Japan, assess coronary risk factors compre-
hensively and arrange education programmes for
individual patients. Finally, the indicators were grouped
as follows: (1) chronic disease as coronary risk factors
and the preventive behaviour, (2) consumption of
Figure 1 Flow chart of the
literature search. *Agency for




Rehabilitation website and the
Japanese Circulation Society
website.
Figure 2 Flow chart of quality indicator selection.
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non-essential grocery items which increases coronary
risk, such as tobacco and alcohol, and (3) psychological
responses.
Of the 20 primary indicators, the panel reconstructed
four indicators. The indicator ‘assessment and education
regarding coronary risk factors’ was developed by com-
bining the following 13 primary indicators: ‘hyperten-
sion assessment’, ‘education for patients with
hypertension’, ‘target blood pressure goal achievement’,
‘assessment and education regarding blood lipids’,
‘reassessment of blood lipids’, ‘assessment and educa-
tion regarding physical activity habits’, ‘intervention for
physical activity habits’, ‘reassessment of physical daily
activity’, ‘assessment of body weight’, ‘intervention for
body weight control’, ‘assessment of diabetes’, ‘interven-
tion for diabetes’, and ‘target glycated haemoglobin
goal achievement’. Some panel members noted that
clinicians tend to deal with these issues together rather
than separately. As such, they agreed that combining
these indicators would make it easier to perform high-
quality measurements. The panel agreed that you judge
to be met the criteria when there is a record regarding
assessment and education on at least one of the coron-
ary risk factor aforementioned or a record that a patient
have none of the risks.
The two primary indicators, ‘assessment of depression’
and ‘intervention for a patient suspected of having
depression’, gave rise to the indicator ‘assessment of psy-
chological responses’. Patients with coronary disease
often have psychological issues such as depression,
anxiety or insomnia.20 56 Furthermore, the panel was of
the opinion that patients in Japan rarely receive appro-
priate assessments, aside from interventions they receive
for CR.
The indicator ‘assessment and education regarding
tobacco and alcohol’ was generated by combining the
Figure 3 Rating distribution of
candidate indicators. The X-axis
indicates individual indicator
evaluation by the panel (1:
disagree, 9: agree). The Y-axis
indicates the number of panel
members who scored the
indicator. *This candidate
indicator did not gain consensus
and was discarded in round 2.
†This was an updated indicator
that includes referral from
outpatient settings as well as
inpatient settings.
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following three primary indicators: ‘assessment of
tobacco use’, ‘support of smoking cessation’ and ‘educa-
tion on alcohol’. The panel agreed that combining
these items would improve measurement quality in clin-
ical settings, as clinicians typically deal with these issues
together. It also agreed that you judge to be met the cri-
teria when there is a record regarding assessment of
tobacco and alcohol use and education on them if it is
necessary.
The primary indicator counselling to return to work
was reworded as ‘assessment and education regarding
work and leisure’. The panel agreed that it was import-
ant for a patient requiring rehabilitation to enjoy leisure
activities, in addition to returning to work.
In addition to the indicators discussed above, the
panel suggested some indicators, including ‘deﬁnition
of programme end period’ and ‘continued participation
in rehabilitation programme’. These indicators were
generated after some panel members emphasised the
importance of completing the CR programme. Given
the multidisciplinary nature of the rehabilitation team,
the generation of another indicator (holding a multidis-
ciplinary conference) was suggested.
In the end, a total of 13 quality indicators were pro-
posed. These indicators spanned the following domains:
(1) referral to CR, (2) modiﬁcation of coronary risk
factors, (3) exercise prescription, (4) completion of the
CR programme, (5) return to social activity, (6) involve-
ment of a multidisciplinary team, (7) management of
prescription medication and (8) communication with
other healthcare providers (table 1).
Performance in the pilot practice test
Of the 39 assessed patients (22 with acute myocardial
infarction and 17 with unstable angina), 29 (74%) parti-
cipated in a CR programme (QI-1, table 1). The median
performance, based on QI-2 to QI-13, was 93% (IQR
46–100). Indicators for which data are collected for
national insurance claims (QI-2, 3, 4, 5, 6, 8, 10 and 12)
showed high performance (median 100%; minimum to
maximum 74–100), whereas others, including QI-7, 9,
11 and 13, showed low performance (minimum to
maximum, 32–48%).
DISCUSSION
In this study, we proposed 13 quality indicators for asses-
sing CR in patients who suffered from acute coronary
syndrome in Japan. A widely used consensus approach,
the modiﬁed Delphi method, with a Japanese multidis-
ciplinary panel identiﬁed seven crucial domains for the
quality measurement. On the basis of results of the
single-site, small-size practice test, we found that most of
the indicators proposed were measurable in real-world
clinical practice and the performance for which data are
collected for national insurance claims was high,
whereas performance of indicators for which data are
recorded voluntarily was low.






Domain 1: referral to cardiac
rehabilitation
QI-1: referral to cardiac rehabilitation 29/39 74
QI-2: assessment and education regarding eating
habits
29/29 100
Domain 2: modification of coronary risk
factors
QI-3: assessment and education regarding
coronary risk factors
29/29 100
QI-4: assessment of psychological responses 28/29 97
QI-5: assessment and education regarding tobacco
and alcohol
29/29 100
Domain 3: exercise therapy QI-6: prescribed exercise based on assessment of
exercise capacity
20/27 74
QI-7: reassessment of exercise capacity 11/24 46
Domain 4: completion of the cardiac
rehabilitation programme
QI-8: definition of the programme end period 29/29 100
QI-9: continued participation in the rehabilitation
programme
8/21 38
Domain 5: return to social activity QI-10: assessment and education regarding work
and leisure
29/29 100
Domain 6: involvement of
multidisciplinary team
QI-11: holding a multidisciplinary conference 14/29 48
Domain 7: management of prescription
medication
QI-12: education on the importance of adherence
to prescription medication
26/29 90
Domain 8: communication with other
healthcare providers
QI-13: communication with a doctor who referred
the patient to cardiac rehabilitation
8/25 32
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The structure of our proposed indicators is consistent
with those reported in previous studies. A few reports have
been published that deal with quality measures for CR in
North America. ACC/AHA/American Association of
Cardiovascular and Pulmonary Rehabilitation (AACVPR)
provided a performance measure set that has (1) referral
to CR and (2) performance in the programme as major
parts.20 21 The Canadian Cardiovascular Society also ori-
ginally developed quality indicators on CR, and then
prioritised a list of ﬁve indicators, including (1) inpatients
referred to CR; (2) wait times from referral to CR enrol-
ment; (3) patient self-management education; (4)
increase in exercise capacity and (5) emergency response
strategy.22 27 In this study, our set of indicators reﬂects the
importance of referral to CR and a comprehensive pro-
gramme. Therefore, we consider these to be essential ele-
ments of quality indicators for CR. Additionally, our study
includes a measurement for the completion of CR, which
is common with a measure set of the USA. It is because
completion of the prescribed course of the programme is
a key to promoting patients’ lifelong behaviour change
and physiological adaptations from regular exercise.20
During the process of developing quality indicators,
pilot practice tests prior to implementation are import-
ant for determining which indicators become estab-
lished components because they evaluate validity,
reliability and feasibility.24 Some studies in other medical
ﬁelds (eg, neck tumours, diabetes, pneumonia) have
reported that, among accepted indicators in the devel-
opment process, ∼10–30% were not measurable or
inapplicable.57 58 In the ﬁeld of CR in the USA, Thomas
et al26 revealed that reliability of the abstraction for the
measure regarding referral was good to excellent. In
addition, with respect to Canadian indicators, Grace
et al27 assessed feasibility and concluded that the indica-
tor assessment was acceptable for the CR programme.
Unlike the previous studies, our practice test was small-
sized but included all indicators proposed. Although the
generalisability is limited, we found a possibility that
some processes for which data were not recorded per
healthcare insurance regulations have low performance.
Therefore, the result suggests that incentives such as
insurance coverage can improve performance in clinical
practice and recording the process. Since Grace et al27
also reported that the information-tracking process was
challenging when measuring quality, which may be a
common issue in the ﬁeld of CR across countries.
Further studies will be needed to make quality measure-
ments more appropriate and efﬁcient.
Although panel nomination is one of the key elements
of quality indicator development, many studies lack
transparency in the process.24 To increase transparency,
our study established the following explicit criteria: (1)
the panel members must have an authorised licence
from an academic society, (2) at least one member is
selected from every relevant profession and (3) the
panel involves some members who have experiences of
CR guideline development. Finally, our panel included
the people concerned with the committee on the clin-
ical practice guidelines for CR jointly developed by the
relevant academic societies in Japan (ie, Shunichi
Ishihara and Shinji Sato who are respectively a member
and collaborator of the committee).59
In contrast to previous reports from the USA and
Canada, our study did not directly stand on the initiative
of any academic society. However, there were opportun-
ities for authorised experts of CR to express his or her
views into the present quality indicators.
The adaptability of each quality indicator must be
reviewed before implementation because healthcare
systems and social circumstances differ. This is a key
element in evidence-based clinical decision-making.60 61
We consider, however, disclosing the explicit process of
guideline-based quality indicator development, which is
a time-efﬁcient and resource-saving approach,24 will be
helpful for people attempting to develop similar quality
indicators in other regions or different social levels.
CONCLUSION
Using an explicit and integrated approach based on evi-
dence and the consensus of a multidisciplinary panel,
we proposed 13 speciﬁc indicators to measure the
quality of CR for patients who experienced acute coron-
ary events in Japan. The practice test was small-sized but
helpful to conﬁrm the measurability of all indicators
proposed, and suggested that incentives such as insur-
ance coverage can improve performance in clinical prac-
tice and recording the process. Further studies will be
needed to clarify the reasons for this, as well as to
improve the quality of care in CR.
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